학술논문
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial
Document Type
Article
Author
Brittain, G.; Sharrack, B.; Petrie, J.; Duffy, K.E.M.; Glover, R.; Hullock, K.; Papaioannou, D.; Bursnall, M.; Cooper, C.; Roldan, E.; Snowden, J.A.; Beecher, C.; Ciccarelli, O.; Coles, A.J.; Giovannoni, G.; Gabriel, I.; Kazmi, M.; Kyriakou, C.; Nicholas, R.; Paling, D.; Peniket, A.; Scolding, N.; Silber, E.; de Silva, T.; Venneri, A.; Walters, S.J.; Young, C.; Muraro, P.A.
Source
In: BMJ Open . (BMJ Open, 5 February 2024, 14(2))
Subject
Language
English
ISSN
20446055